Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
Steven Le Gouill, Monika Długosz‐Danecka, Simon Rule, Pier Luigi Zinzani, André Goy, Stephen D. Smith, Jeanette K. Doorduijn, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Eric D. Jacobsen, Arnon P. Kater, Tadeusz Robak, Preetesh Jain, Roser Calvo, Lin Tao, Michael Wang
Abstract
Not available.
Topics & Concepts
Mantle cell lymphomaInternal medicineMedicineRefractory (planetary science)OncologyLymphomaOverall survivalMaterials scienceMetallurgyLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchViral-associated cancers and disorders